BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 11040236)

  • 1. Blockade of the renin-angiotensin and endothelin systems on progressive renal injury.
    Cao Z; Cooper ME; Wu LL; Cox AJ; Jandeleit-Dahm K; Kelly DJ; Gilbert RE
    Hypertension; 2000 Oct; 36(4):561-8. PubMed ID: 11040236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin-angiotensin system blockade alone or combined with ET
    Sedláková L; Čertíková Chábová V; Doleželová Š; Škaroupková P; Kopkan L; Husková Z; Červenková L; Kikerlová S; Vaněčková I; Sadowski J; Kompanowska-Jezierska E; Kujal P; Kramer HJ; Červenka L
    Clin Exp Hypertens; 2017; 39(2):183-195. PubMed ID: 28287881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of ET(A) receptor blockade increases renoprotection provided by renin-angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats.
    Čertíková Chábová V; Vernerová Z; Kujal P; Husková Z; Škaroupková P; Tesař V; Kramer HJ; Kompanowska-Jezierska E; Walkowska A; Sadowski J; Červenka L; Vaněčková I
    Life Sci; 2014 Nov; 118(2):297-305. PubMed ID: 24373834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal damage is not improved by blockade of endothelin receptors in primary renin-dependent hypertension.
    Rothermund L; Kossmehl P; Neumayer HH; Paul M; Kreutz R
    J Hypertens; 2003 Dec; 21(12):2389-97. PubMed ID: 14654760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure-independent additive effects of pharmacologic blockade of the renin-angiotensin and endothelin systems on progression in a low-renin model of renal damage.
    Amann K; Simonaviciene A; Medwedewa T; Koch A; Orth S; Gross ML; Haas C; Kuhlmann A; Linz W; Schölkens B; Ritz E
    J Am Soc Nephrol; 2001 Dec; 12(12):2572-2584. PubMed ID: 11729225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of combined endothelin A receptor and renin-angiotensin system blockade on the course of end-organ damage in 5/6 nephrectomized Ren-2 hypertensive rats.
    Vaněčková I; Kujal P; Husková Z; Vaňourková Z; Vernerová Z; Certíková Chábová V; Skaroupková P; Kramer HJ; Tesař V; Červenka L
    Kidney Blood Press Res; 2012; 35(5):382-92. PubMed ID: 22487948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat.
    Kelly DJ; Skinner SL; Gilbert RE; Cox AJ; Cooper ME; Wilkinson-Berka JL
    Kidney Int; 2000 May; 57(5):1882-94. PubMed ID: 10792607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Add-on angiotensin receptor blockade with maximized ACE inhibition.
    Agarwal R
    Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular basis of increased glomerulosclerosis after blockade of the renin angiotensin system in growth hormone transgenic mice.
    Peten EP; Striker LJ; Fogo A; Ichikawa I; Patel A; Striker GE
    Mol Med; 1994 Nov; 1(1):104-15. PubMed ID: 8790606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of Endothelin A-Receptor Blockade Spoils the Beneficial Effect of Combined Renin-Angiotensin and Soluble Epoxide Hydrolase Inhibition: Studies on the Course of Chronic Kidney Disease in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats.
    Čertíková Chábová V; Kujal P; Vaňourková Z; Škaroupková P; Sadowski J; Kompanowska-Jezierska E; Tesař V; Hammock B; Imig J; Maxová H; Červenka L; Vaněčková I
    Kidney Blood Press Res; 2019; 44(6):1493-1505. PubMed ID: 31770762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
    Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G
    Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts.
    Yamamoto K; Masuyama T; Sakata Y; Mano T; Nishikawa N; Kondo H; Akehi N; Kuzuya T; Miwa T; Hori M
    Cardiovasc Res; 2000 Aug; 47(2):274-83. PubMed ID: 10946064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney.
    Benigni A; Zola C; Corna D; Orisio S; Facchinetti D; Benati L; Remuzzi G
    Am J Kidney Dis; 1996 Mar; 27(3):416-23. PubMed ID: 8604712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive effects of a mixed endothelin-A- and -B-receptor antagonist, J-104132, were augmented in the presence of an AT1 -receptor antagonist, MK-954.
    Ikeda T; Ohta H; Okada M; Kawai N; Nakao R; Siegl PK; Kobayashi T; Miyauchi T; Nishikibe M
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S337-41. PubMed ID: 11078414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis.
    Naito T; Ma LJ; Yang H; Zuo Y; Tang Y; Han JY; Kon V; Fogo AB
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F683-91. PubMed ID: 20042458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate additive effects of endothelin receptor A blockade in Ren-2 transgenic rats subjected to various types of RAS blockade.
    Vaněčková I; Řezáčová L; Kuneš J; Zicha J
    Life Sci; 2016 Aug; 159():127-134. PubMed ID: 26775568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of blocking renin-angiotensin system on the progression of renal injury in glomerulosclerosis.
    Ji Z; Huang C; Liang C; Chen B; Chen S; Sun W
    Cell Mol Immunol; 2005 Apr; 2(2):150-4. PubMed ID: 16191423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive hypotensive and anti-albuminuric effects of angiotensin-converting enzyme inhibition and angiotensin receptor antagonism in diabetic spontaneously hypertensive rats.
    Cao Z; Bonnet F; Davis B; Allen TJ; Cooper ME
    Clin Sci (Lond); 2001 Jun; 100(6):591-9. PubMed ID: 11352773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-Specific Effect of Endothelin in the Blood Pressure Response to Acute Angiotensin II in Growth-Restricted Rats.
    Intapad S; Ojeda NB; Varney E; Royals TP; Alexander BT
    Hypertension; 2015 Dec; 66(6):1260-6. PubMed ID: 26459423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.